V. Craig Jordan - Concepedia

Author

V. Craig Jordan

Also Known As

Jordan, V. Craig, M Andersson, V C Jordan, V C. Jordan, V Craig Jordan, V JORDAN, V Jordan, V. C. JORDAN, V. C. Jordan, V. CRAIG JORDAN

571

Publications

25.9K

Citations

H-Index

118

Concepts

All Affiliations

University of Wisconsin–Madison Breast Cancer Care Northwestern University University of Wisconsin Carbone Cancer Center Georgetown University

About

V. Craig Jordan is an author at University of Wisconsin–Madison specializing in medicine, breast cancer, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	53	140	10.3K
2	Health Sciences	13	13	664
3	Public Health	10	10	838
4	Natural Sciences	5	5	409
5	Engineering	3	3	57

V. Craig Jordan

200

Publications

15.9K

Citations

H-Index

Page 1

	Year	Citations
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer Richard R. Love, Richard B. Mazess, Howard S. Barden, New England Journal of Medicine	1992	1.1K
Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial Jane A. Cauley, Larry Norton, Marc E. Lippman, Breast Cancer Research and Treatment Breast OncologyOncologyMore TrialCancer ManagementClinical Trials	2001	680
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer Victor G. Vogel, Joseph P. Costantino, D. Lawrence Wickerham, Cancer Prevention Research Serm RaloxifeneSelective Estrogen-receptor ModulatorSurgical OncologyOncologyBreast Oncology	2010	637
A MONOHYDROXYLATED METABOLITE OF TAMOXIFEN WITH POTENT ANTIOESTROGENIC ACTIVITY V. Craig Jordan, Margaret Collins, Linda Rowsby, Journal of Endocrinology	1977	501
Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Marco M. Gottardis, Simon P. Robinson, P.G. Satyaswaroop, PubMed Antiestrogen TamoxifenEndocrine-related CancerMedicineEstradiol-stimulated GrowthBreast Tumor Growth	1988	423
Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture. Leonard J. Lerner, V. Craig Jordan PubMed Laboratory DiscoveryHormonal ContraceptiveBreast OncologyClinical TestingMedicine	1990	419
MCF-7: the first hormone-responsive breast cancer cell line. Anait S. Levenson, V. Craig Jordan PubMed Tumor BiologyBreast OncologyMedicineCancer Cell BiologyBreast Cancer	1997	415
Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal Women Richard R. Love, Donald A. Wiebe, Polly A. Newcomb, Annals of Internal Medicine	1991	375
Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial Victor G. Vogel, Joseph P. Costantino, D. Lawrence Wickerham, Obstetrical & Gynecological Survey Surgical OncologyBreast OncologyGynecologyPharmacotherapyOther Disease Outcomes	2006	330
Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells Pilar García-Morales, Miguel Saceda, Nicholas Kenney, Journal of Biological Chemistry Breast OncologyEstrogen ReceptorMammary Gland DevelopmentOxidative StressToxicology	1994	324

Page 1